Copyright
©2014 Baishideng Publishing Group Inc.
World J Stem Cells. Nov 26, 2014; 6(5): 614-619
Published online Nov 26, 2014. doi: 10.4252/wjsc.v6.i5.614
Published online Nov 26, 2014. doi: 10.4252/wjsc.v6.i5.614
Figure 4 A schematic representation showing cancer stem cells resistance to chemo-and radio-therapy causing tumor to relapse.
Cancer stem cells (CSCs) (yellow) with differentiated cells committed to a particular lineage (red). Ability of CSCs to resist anti-cancer therapy due to various mechanisms and ability to proliferate into heterogeneous group of cells cause tumor to relapse. HMGA2: High mobility group A2; ABCG2: ATP-binding cassette sub-family G member 2; MDR1: Multi-drug resistance protein-1; IGF: Insulin-derived growth factor; EGF: Epidermal growth factor; bFGF: Basic fibroblast growth factor.
- Citation: Bhatia P, Tsumagari K, Abd Elmageed ZY, Friedlander P, Buell JF, Kandil E. Stem cell biology in thyroid cancer: Insights for novel therapies. World J Stem Cells 2014; 6(5): 614-619
- URL: https://www.wjgnet.com/1948-0210/full/v6/i5/614.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v6.i5.614